Latest News about covid/19 vaccine
Recent news which mentions covid/19 vaccine
Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study
December 22, 2021
Tickers
NVAX
From Benzinga
Novavax's COVID-19 Vaccine Scores Conditional Approval In Europe
December 20, 2021
Tickers
NVAX
From Benzinga
Moderna's Authorized COVID-19 Booster Increases Omicron Neutralizing Antibody Levels 37-Fold
December 20, 2021
Tickers
MRNA
From Benzinga
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
From Benzinga
Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
December 16, 2021
Tickers
VALN
From Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
From Benzinga
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
December 15, 2021
Tickers
GOVX
From Benzinga
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
December 15, 2021
Tickers
OCGN
From Benzinga
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection
December 14, 2021
From Benzinga
Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: Reuters
December 14, 2021
Tickers
NVAX
From Benzinga
Moderna, Australia Collaborate To Bring mRNA Manufacturing To Australia
December 14, 2021
Tickers
MRNA
From Benzinga
FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & Older
December 09, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows
December 08, 2021
From Benzinga
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
December 07, 2021
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.